Rachel Smith, PA
Surgical · Nashville, TNNPI 1881065845
Payments from drug & device makers
What this record shows
Pacira Pharmaceuticals Incorporated accounts for 66.0% of it on its own, with 12 other manufacturers making up the rest. Reporting peaked in 2024 at $1,182 and has fallen 98.8% since, to $14 in 2025.
Across 39 payments — averaging $45.94 each. Meals, travel, consulting and speaking fees, gifts and royalties reported by drug and device makers.
- Pacira Pharmaceuticals Incorporated$1K
- Endo Pharmaceuticals Inc.$243
- Pacira Therapeutics, Inc.$128
- Amgen$46
- Johnson & Johnson$42
- Vertos Medical, Inc.$28
- plus $123 from 7 others
What the payments were for
- Travel & lodging$1,00356%
- Food & beverage$78944%
General payments by program year
Who reported the general payments
Companies are grouped under their corporate parent — a single manufacturer often files under several CMS reporting entities. Research and ownership payments are counted separately and are not in this table.
| Company | Payments | Total |
|---|---|---|
| Pacira Pharmaceuticals Incorporated | 6 | $1,182 |
| Endo Pharmaceuticals Inc. | 14 | $243 |
| Pacira Therapeutics, Inc. | 5 | $128 |
| Amgen | 3 | $46 |
| Johnson & Johnson | 3 | $42 |
| Vertos Medical, Inc. | 1 | $28 |
| Sanofi-aventis U.S. LLC | 1 | $23 |
| Baxter Healthcare | 1 | $22 |
| Ultragenyx Pharmaceutical Inc. | 1 | $22 |
| Radius Health, Inc. | 1 | $18 |
| Curonix LLC | 1 | $14 |
| Acelrx Pharmaceuticals, Inc. | 1 | $14 |
| Heron Therapeutics, Inc. | 1 | $9 |
What the payments were tied to
Products named in the reported payments. Only payments of $100 or more are attributed here — the typical reported payment nationally is a meal worth about $16, and listing those product-by-product would be noise.
- Iovera$1,129
How this compares
$1,792 in reported general payments places this provider in the 80th percentile of 206 surgical providers in Tennessee.
Medicare billing
What this is not: this is the amount Original Medicare Part B allowed for services this provider billed in 2024. It is not their income. It excludes Medicare Advantage — now more than half of all Medicare enrollment — along with Medicaid and all commercial insurance, and it is gross practice revenue before staff, rent, supplies and malpractice premiums. CMS also suppresses any figure covering ten or fewer patients, so low-volume providers appear smaller than they are.
Most prescribed under Part D
| Drug | Claims | Cost to plans & patients |
|---|---|---|
| Diclofenac Sodium | 29 | $562 |
| Meloxicam | 107 | $370 |
| Hydrocodone-AcetaminophenHydrocodone/Acetaminophen | 40 | $255 |
| Celecoxib | 18 | $187 |
| Methylprednisolone | 18 | $160 |
Paid to pharmacies, not to this prescriber.
Other surgical in Nashville
- Stephen DevriesNashville$57K
- Elizabeth HaggertyNashville$9K
- Matthew HawkinsNashville$4K
- Jessica BloomNashville$2K
- Edward OsuigweNashville$2K
- Mitchell HainesNashville$2K
- Jennie ClarkKnoxville$5K
- Lacy ConryBartlett$5K
- Caleb StephensJohnson City$5K
- Christopher DalbyKnoxville$4K
Where these figures come from
- Payments: CMS Open Payments, program years 2019–2025 (publication P06302026_06032026).
- Billing: Medicare Physician & Other Practitioners, data year 2024. Original Medicare Part B only.
- Identity: NPPES NPI Registry, July 2026.